FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Proteinase Activated Receptor 4 in the Jejunum of Healthy Ho...
Frontiers in veterinary science2020; 7; 158; doi: 10.3389/fvets.2020.00158

Proteinase Activated Receptor 4 in the Jejunum of Healthy Horses and of Horses With Epiploic Hernia.

Abstract: Proteinase activated receptor 4 (PAR) in the gastrointestinal tract is involved in the regulation of inflammation and pain pathways. The aim of the present study was to evaluate the distribution and expression of PAR in the jejunum of healthy horses and in the pathologic tracts from horses undergoing surgery for herniation of the small intestine through the epiploic foramen. Eight healthy horses (Group H) and eight horses with epiploic hernia (Group EH) were included; the jejunum samples were collected at the slaughter or intraoperatively after enterectomy, respectively. To evaluate PAR expression in sections of the jejunum, immunofluorescence, western blot and quantitative polymerase chain reaction (qRT-PCR) were performed. Immunohistochemistry of PAR in the jejunum of the healthy horses showed that receptors are predominantly expressed in the immune cell population scattered throughout the lamina propria of the mucosa and in the submucosa. Quantitative PCR data demonstrated that PAR mRNA was detectable in all of the samples analyzed without any difference between the H and the EH groups, however the PAR protein level was significantly lower in the jejunums of the EH horses. In the Group EH horses, PAR immunoreactivity was mainly expressed in the mast cells and was extensively distributed in the sierosa. In the lamina propria of mucosa of Group EH, leukocytes were less abundant than in Group H. In this study, the distribution and expression of PAR in the jejunums of the healthy horses and in those with spontaneous occurring epiploic hernia was demonstrated.
Copyright © 2020 Lambertini, Bombardi, Zannoni, Bernardini, Dondi, Morini, Rinnovati, Spadari and Romagnoli.
Get Full Text
Publication Date: 2020-03-31 PubMed ID: 32296721PubMed Central: PMC7136499DOI: 10.3389/fvets.2020.00158Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on examining the role of Proteinase Activated Receptor 4 (PAR) in the jejunum (part of the small intestine) of healthy horses and horses with epiploic hernia, with a particular focus on its relation to inflammation and pain pathways.

Overview of the Study

  • The study aimed to understand the distribution and expression of Proteinase Activated Receptor 4 (PAR4) in the jejunums of both healthy horses and horses with an epiploic hernia, a specific form of intestinal herniation.
  • The research featured two groups: Group H, consisting of eight healthy horses, and Group EH, made of eight horses with an epiploic hernia.
  • Samples from the jejunum, a section of the small intestine, were collected from the horses either during slaughter (for Group H) or during surgery to rectify the herniation (for Group EH).

Research Methods

  • The researchers employed several methods to evaluate the expression of PAR4 in the jejunum samples, including immunofluorescence, western blot, and quantitative polymerase chain reaction (qRT-PCR).
  • Immunohistochemistry, a technique used to localize proteins in cells of tissue sections, was used to observe the location of the PAR4 in the jejunal tissue.

Results and Conclusions

  • The results revealed that in healthy horses, PAR4 receptors were mainly expressed in immune cells present in the lamina propria of the mucosa and in the submucosa.
  • Messenger RNA (mRNA) for PAR was found across all samples, with no significant variation between Group H and Group EH. This indicates that PAR4 expression at the gene level was pretty constant regardless of the health status of the horse.
  • However, there was a significant difference at the protein level. PAR4 protein was found to be significantly lower in the jejunums of the Group EH horses compared to the healthy group.
  • In terms of distribution, in Group EH horses, PAR4 was mainly found in mast cells and was distributed significantly across the serosa (the inner lining of the abdomen).
  • In comparison to Group H, Group EH jejunums had fewer leukocytes in the lamina propria of mucosa, which could possibly imply a reduction in the immune response due to the herniation.
  • The study successfully highlighted the difference in distribution and expression of PAR4 in healthy horses and those with a hernia, serving as a starting point for further investigations on the role of PAR4 in equine gastrointestinal diseases.

Cite This Article

APA
Lambertini C, Bombardi C, Zannoni A, Bernardini C, Dondi F, Morini M, Rinnovati R, Spadari A, Romagnoli N. (2020). Proteinase Activated Receptor 4 in the Jejunum of Healthy Horses and of Horses With Epiploic Hernia. Front Vet Sci, 7, 158. https://doi.org/10.3389/fvets.2020.00158

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 7
Pages: 158
PII: 158

Researcher Affiliations

Lambertini, Carlotta
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Bombardi, Cristiano
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Zannoni, Augusta
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Bernardini, Chiara
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Dondi, Francesco
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Morini, Maria
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Rinnovati, Riccardo
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Spadari, Alessandro
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.
Romagnoli, Noemi
  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano Dell'Emilia, Italy.

References

This article includes 48 references
  1. Youssef HA, Ali MM, Kuraa HMM. Effect of small intestine strangulation obstruction on clinical and histopathological parameters. An experimental study in donkeys.. Vet Res Forum (2011) 2:75–86.
  2. Wong DM, Moore RM, Brockus CW. Intestinal ischemia-reperfusion injury in horses: pathogenesis and therapeutics.. Compend Contin Educ Vet 2012 Aug;34(8):E5.
    pubmed: 22935993
  3. Hao Y, Niu H, An S, Wang M, Wang Z. Downregulation of iNOS, IL-1β, and P2X7 Expression in Mast Cells via Activation of PAR4 Contributes to the Inhibition of Visceral Hyperalgesia in Rats.. J Immunol Res 2018;2018:3256908.
    doi: 10.1155/2018/3256908pmc: PMC5966670pubmed: 29854833google scholar: lookup
  4. Phillips TJ, Walmsley JP. Retrospective analysis of the results of 151 exploratory laparotomies in horses with gastrointestinal disease.. Equine Vet J 1993 Sep;25(5):427-31.
    doi: 10.1111/j.2042-3306.1993.tb02985.xpubmed: 8223375google scholar: lookup
  5. Vachon AM, Fischer AT. Small intestinal herniation through the epiploic foramen: 53 cases (1987-1993).. Equine Vet J 1995 Sep;27(5):373-80.
    doi: 10.1111/j.2042-3306.1995.tb04073.xpubmed: 8654353google scholar: lookup
  6. Sullins KE, Stashak TS, Mero KN. Pathologic changes associated with induced small intestinal strangulation obstruction and nonstrangulating infarction in horses.. Am J Vet Res 1985 Apr;46(4):913-6.
    pubmed: 4014840
  7. Freeman DE. Small intestine. Equine Surgery fourth ed. St. Luis, MI: Elsevier (2012). p. 416–53.
    doi: 10.1016/B978-1-4377-0867-7.00036-3google scholar: lookup
  8. Faleiros RR, Alves GES, Santos RL, Marques AP, Junior, Macoris DG. Experimental ischemia and reperfusion in equine small colon. Arq Bras Med Vet Zootec (2001) 53:341–50.
    doi: 10.1590/S0102-09352001000300012google scholar: lookup
  9. Bradesi S. PAR4: a new role in the modulation of visceral nociception.. Neurogastroenterol Motil 2009 Nov;21(11):1129-32.
    doi: 10.1111/j.1365-2982.2009.01373.xpmc: PMC2771625pubmed: 19804483google scholar: lookup
  10. Han W, Wang Z, Lu X, Guo C. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome.. Neurogastroenterol Motil 2012 Feb;24(2):113-9, e82.
    doi: 10.1111/j.1365-2982.2011.01841.xpubmed: 22151913google scholar: lookup
  11. Mulè F, Pizzuti R, Capparelli A, Vergnolle N. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon.. Gut 2004 Feb;53(2):229-34.
    doi: 10.1136/gut.2003.021899pmc: PMC1774912pubmed: 14724155google scholar: lookup
  12. Zhao JH, Dong L, Shi HT, Wang ZY, Shi HY, Ding H. The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients.. Dig Dis Sci 2012 Jan;57(1):58-64.
    doi: 10.1007/s10620-011-1827-3pubmed: 21800160google scholar: lookup
  13. Antalis TM, Shea-Donohue T, Vogel SN, Sears C, Fasano A. Mechanisms of disease: protease functions in intestinal mucosal pathobiology.. Nat Clin Pract Gastroenterol Hepatol 2007 Jul;4(7):393-402.
    doi: 10.1038/ncpgasthep0846pmc: PMC3049113pubmed: 17607295google scholar: lookup
  14. Fender AC, Rauch BH, Geisler T, Schrör K. Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?. Thromb Haemost 2017 Nov;117(11):2013-2025.
    doi: 10.1160/TH17-03-0219pubmed: 29044290google scholar: lookup
  15. Vergnolle N. Proteinase-activated receptors (PARs) in infection and inflammation in the gut.. Int J Biochem Cell Biol 2008;40(6-7):1219-27.
    doi: 10.1016/j.biocel.2008.01.016pubmed: 18313348google scholar: lookup
  16. Vergnolle N. Protease inhibition as new therapeutic strategy for GI diseases.. Gut 2016 Jul;65(7):1215-24.
    doi: 10.1136/gutjnl-2015-309147pmc: PMC4941139pubmed: 27196587google scholar: lookup
  17. Dabek M, Ferrier L, Roka R, Gecse K, Annahazi A, Moreau J, Escourrou J, Cartier C, Chaumaz G, Leveque M, Ait-Belgnaoui A, Wittmann T, Theodorou V, Bueno L. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.. Am J Pathol 2009 Jul;175(1):207-14.
    doi: 10.2353/ajpath.2009.080986pmc: PMC2708807pubmed: 19528350google scholar: lookup
  18. Mueller K, Michel K, Krueger D, Demir IE, Ceyhan GO, Zeller F, Kreis ME, Schemann M. Activity of protease-activated receptors in the human submucous plexus.. Gastroenterology 2011 Dec;141(6):2088-2097.e1.
    doi: 10.1053/j.gastro.2011.08.034pubmed: 21875497google scholar: lookup
  19. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC. Cloning and characterization of human protease-activated receptor 4.. Proc Natl Acad Sci U S A 1998 Jun 9;95(12):6642-6.
    doi: 10.1073/pnas.95.12.6642pmc: PMC22580pubmed: 9618465google scholar: lookup
  20. Annaházi A, Dabek M, Gecse K, Salvador-Cartier C, Polizzi A, Rosztóczy A, Róka R, Theodorou V, Wittmann T, Bueno L, Eutamene H. Proteinase-activated receptor-4 evoked colorectal analgesia in mice: an endogenously activated feed-back loop in visceral inflammatory pain.. Neurogastroenterol Motil 2012 Jan;24(1):76-85, e13.
    doi: 10.1111/j.1365-2982.2011.01805.xpubmed: 22044612google scholar: lookup
  21. Asfaha S, Cenac N, Houle S, Altier C, Papez MD, Nguyen C, Steinhoff M, Chapman K, Zamponi GW, Vergnolle N. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation.. Br J Pharmacol 2007 Jan;150(2):176-85.
    doi: 10.1038/sj.bjp.0706975pmc: PMC2042908pubmed: 17179954google scholar: lookup
  22. Augé C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity.. Neurogastroenterol Motil 2009 Nov;21(11):1189-e107.
    doi: 10.1111/j.1365-2982.2009.01310.xpubmed: 19413681google scholar: lookup
  23. Hollenberg MD, Saifeddine M, Sandhu S, Houle S, Vergnolle N. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo.. Br J Pharmacol 2004 Oct;143(4):443-54.
    doi: 10.1038/sj.bjp.0705946pmc: PMC1575414pubmed: 15451771google scholar: lookup
  24. Packer M, Patterson-Kane JC, Smith KC, Durham AE. Quantification of immune cell populations in the lamina propria of equine jejunal biopsy specimens.. J Comp Pathol 2005 Jan;132(1):90-5.
    doi: 10.1016/j.jcpa.2004.06.002pubmed: 15629483google scholar: lookup
  25. Van Hoogmoed L, Snyder JR, Pascoe JR, Olander H. Use of pelvic flexure biopsies to predict survival after large colon torsion in horses.. Vet Surg 2000 Nov-Dec;29(6):572-7.
    doi: 10.1053/jvet.2000.17836pubmed: 11098791google scholar: lookup
  26. Zannoni A, Bombardi C, Dondi F, Morini M, Forni M, Chiocchetti R, Spadari A, Romagnoli N. Proteinase-activated receptor 2 expression in the intestinal tract of the horse.. Res Vet Sci 2014 Jun;96(3):464-71.
    doi: 10.1016/j.rvsc.2014.03.006pubmed: 24656343google scholar: lookup
  27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.. Methods 2001 Dec;25(4):402-8.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  28. Romagnoli N, Zannoni A, Bernardini C, Gobbetti T, Bombardi C, Rambaldi AM, Morini M, Dondi F, Rinnovati R, Lambertini C, Spadari A. Proteinase-activated receptor 2 distribution and expression in equine small intestine tracts following herniation through the epiploic foramen.. Res Vet Sci 2019 Aug;125:434-440.
    doi: 10.1016/j.rvsc.2017.10.006pubmed: 29108655google scholar: lookup
  29. Rullier A, Senant N, Kisiel W, Bioulac-Sage P, Balabaud C, Le Bail B, Rosenbaum J. Expression of protease-activated receptors and tissue factor in human liver.. Virchows Arch 2006 Jan;448(1):46-51.
    doi: 10.1007/s00428-005-0078-0pubmed: 16193294google scholar: lookup
  30. López ML, Soriano-Sarabia N, Bruges G, Marquez ME, Preissner KT, Schmitz ML, Hackstein H. Expression pattern of protease activated receptors in lymphoid cells.. Cell Immunol 2014 Mar-Apr;288(1-2):47-52.
    doi: 10.1016/j.cellimm.2014.02.004pubmed: 24637088google scholar: lookup
  31. Héron A, Dubayle D. A focus on mast cells and pain.. J Neuroimmunol 2013 Nov 15;264(1-2):1-7.
    doi: 10.1016/j.jneuroim.2013.09.018pubmed: 24125568google scholar: lookup
  32. Zuo Y, Perkins NM, Tracey DJ, Geczy CL. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells.. Pain 2003 Oct;105(3):467-479.
    doi: 10.1016/S0304-3959(03)00261-6pubmed: 14527707google scholar: lookup
  33. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.. Gastroenterology 2004 Mar;126(3):693-702.
    doi: 10.1053/j.gastro.2003.11.055pubmed: 14988823google scholar: lookup
  34. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.. Gastroenterology 2007 Jan;132(1):26-37.
    doi: 10.1053/j.gastro.2006.11.039pubmed: 17241857google scholar: lookup
  35. An S, Zong G, Wang Z, Shi J, Du H, Hu J. Activation of protease-activated receptor 4 of mast cells could downregulate proinflammatory cytokines in irritable bowel syndrome.. Gut 2017 Nov;66(11):2040-2042.
    doi: 10.1136/gutjnl-2016-313504pubmed: 28274996google scholar: lookup
  36. Karanjia R, Spreadbury I, Bautista-Cruz F, Tsang ME, Vanner S. Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons.. Neurogastroenterol Motil 2009 Nov;21(11):1218-21.
    doi: 10.1111/j.1365-2982.2009.01353.xpubmed: 19566587google scholar: lookup
  37. French SL, Hamilton JR. Protease-activated receptor 4: from structure to function and back again.. Br J Pharmacol 2016 Oct;173(20):2952-65.
    doi: 10.1111/bph.13455pmc: PMC5341247pubmed: 26844674google scholar: lookup
  38. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease.. Physiol Rev 2004 Apr;84(2):579-621.
    doi: 10.1152/physrev.00028.2003pubmed: 15044683google scholar: lookup
  39. Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y, Wood JD. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine.. Gastroenterology 2002 Nov;123(5):1554-64.
    doi: 10.1053/gast.2002.36581pubmed: 12404230google scholar: lookup
  40. Corvera CU, Déry O, McConalogue K, Gamp P, Thoma M, Al-Ani B, Caughey GH, Hollenberg MD, Bunnett NW. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2.. J Physiol 1999 Jun 15;517 ( Pt 3)(Pt 3):741-56.
    doi: 10.1111/j.1469-7793.1999.0741s.xpmc: PMC2269379pubmed: 10358115google scholar: lookup
  41. Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, Bunnett NW, Vanner SJ. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons.. J Physiol 2003 Mar 1;547(Pt 2):531-42.
    doi: 10.1113/jphysiol.2002.032011pmc: PMC2342663pubmed: 12562962google scholar: lookup
  42. Linden DR, Manning BP, Bunnett NW, Mawe GM. Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons.. Eur J Pharmacol 2001 Nov 23;431(3):311-4.
    doi: 10.1016/S0014-2999(01)01447-9pubmed: 11730723google scholar: lookup
  43. Dolente BA, Wilkins PA, Boston RC. Clinicopathologic evidence of disseminated intravascular coagulation in horses with acute colitis.. J Am Vet Med Assoc 2002 Apr 1;220(7):1034-8.
    doi: 10.2460/javma.2002.220.1034pubmed: 12420783google scholar: lookup
  44. Vandenplas ML, Moore JN, Barton MH, Roussel AJ, Cohen ND. Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic.. Am J Vet Res 2005 Sep;66(9):1509-16.
    doi: 10.2460/ajvr.2005.66.1509pubmed: 16261823google scholar: lookup
  45. El-Zahar H, Bayoumi Y, Shalaby S, Gehlen H, Shety T. Plasma d-dimer concentration in horses with colic. Adv Anim Vet Sci (2018) 6:27–32.
    doi: 10.17582/journal.aavs/2018/6.1.27.32google scholar: lookup
  46. Dondi F, Lukacs RM, Gentilini F, Rinnovati R, Spadari A, Romagnoli N. Serum amyloid A, haptoglobin, and ferritin in horses with colic: Association with common clinicopathological variables and short-term outcome.. Vet J 2015 Jul;205(1):50-5.
    doi: 10.1016/j.tvjl.2015.03.015pubmed: 25981935google scholar: lookup
  47. Pihl TH, Andersen PH, Kjelgaard-Hansen M, Mørck NB, Jacobsen S. Serum amyloid A and haptoglobin concentrations in serum and peritoneal fluid of healthy horses and horses with acute abdominal pain.. Vet Clin Pathol 2013 Jun;42(2):177-83.
    doi: 10.1111/vcp.12031pubmed: 23577834google scholar: lookup
  48. Cesarini C, Monreal L, Armengou L, Delgado MÁ, Ríos J, Jose-Cunilleras E. Association of admission plasma D-dimer concentration with diagnosis and outcome in horses with colic.. J Vet Intern Med 2010 Nov-Dec;24(6):1490-7.
    doi: 10.1111/j.1939-1676.2010.0618.xpubmed: 20946373google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.